We dont know how the prices of novel GLP-1s will change, we dont know what new GLP-1s will be introduced, we dont know how many generics there will be, we dont know how many people will ultimately use them, we dont know how long people will stay on them, we dont know what Medicare drug price negotiations will do to the price, and we dont even know if reducing obesity impacts long-term health spending
A Relationship Already Under Strain @bloombergbusiness On the Big Take podcast, host David Gura and Bloomberg #health reporter Madison Muller track how Hims became the king of copycat #weightloss drugs and whats next for the company as it fights to hold onto the crown
The FDA has approved GLP-1 receptor agonists for specific medical uses, such as managing type 2 diabetes and chronic weight management
403Webshell Server IP : 159.89.25.186 / Your IP : 104.168.8.88 Web Server : Apache/2.4.52 System : Linux zmp 5.15.0-186-generic #196-Ubuntu SMP Sat Jun 20 16:09:34 UTC 2026 x86_64 User : solipasolim ( 1006 ) PHP Version : 8.1.34 Disable Function : NONE MySQL : OFF | cURL : ON | WGET : ON | Perl : ON | Python : OFF | Sudo : ON | Pkexec : ON Directory : / home / solipasolim / public_html / Upload File : current_dir [ Writeable ] document_root [ Writeable ] Command : [ Back ] Name Size Last Modified Owner / Group Permissions Options
Veraldi S, Cavicchini S, Benelli C, Gasparini G
If morning injections cause afternoon energy dips, switching to evening may help
